Literature DB >> 23079368

[Structure and adequacy of the Beck Depression Inventory in patients with fibromyalgia].

María Isabel Comeche Moreno1, José Ortega Pardo, María de la Fe Rodríguez Muñoz, Marta Isabel Díaz, Miguel Ángel Vallejo Pareja.   

Abstract

The Beck Depression inventory is a widely used instrument for the measurement of depression in chronic pain. However, there are no studies that analyze the structure and adequacy of the use of the BDI in these patients. In this work, we have carried out exploratory and confirmatory factor analysis of the results of the BDI in a sample of 300 patients with fibromyalgia. The factor structure of the exploratory BDI yields three factors that include cognitive, emotional and somatic symptoms. The structural equation analyses carried out to confirm the fit of the data in this sample with the models of chronic pain presented in the literature were not significant. These results indicate that there are differences between the depressive manifestations of this type of patients and those with chronic pain. In addition, the peculiar structure of the BDI in this sample of patients seems to indicate an overlap between some depressive symptoms and the symptoms of fibromyalgia, which could lead to an overestimation of the occurrence of depression when measured with the BDI, a bias that should be assessed and modified.

Entities:  

Mesh:

Year:  2012        PMID: 23079368

Source DB:  PubMed          Journal:  Psicothema        ISSN: 0214-9915


  2 in total

1.  Mindfulness training for reducing anger, anxiety, and depression in fibromyalgia patients.

Authors:  Alberto Amutio; Clemente Franco; María de Carmen Pérez-Fuentes; José J Gázquez; Isabel Mercader
Journal:  Front Psychol       Date:  2015-01-12

2.  The effect of depressive symptoms on cognition in patients with fibromyalgia.

Authors:  Olga Gelonch; Maite Garolera; Joan Valls; Gerard Castellà; Olalla Varela; Lluís Rosselló; Josep Pifarre
Journal:  PLoS One       Date:  2018-07-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.